In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million)
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....